"PharmAust’s Executive Chairman, Dr Roger Aston said, "The veterinary applications of PPL-1, particularly for dog cancers, is under a "Research and Option Agreement" with a global company marketing animal health products. The outcome of this trial will be an important milestone for PharmAust".
Some good news on the canine front should spark some decent interest then.
"PharmAust’s Executive Chairman, Dr Roger Aston said, "The...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
-0.005(2.38%) |
Mkt cap ! $81.16M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.0¢ | 20.5¢ | $87.97K | 426.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10300 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 261000 | 3 |
View Market Depth
| Last trade - 15.59pm 26/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |